SMTL ID : 7u9a.1

EGFR in complex with a macrocyclic inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x M19: 4-(5-chloro-4-fluoro-2-hydroxyanilino)-7-methoxyquinazolin-6-ol(Non-covalent)

M19.1: 15 residues within 4Å: Chain A: L.27, A.52, K.54, E.71, M.75, L.97, T.99, Q.100, L.101, M.102, P.103, G.105, L.153, T.163, D.164 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.27, A:K.54, A:T.99, A:L.101 Hydrogen bonds: A:M.102, A:T.163 Halogen bonds: A:L.97

1 x FLC: CITRATE ANION(Non-covalent)

FLC.2: 5 residues within 4Å: Chain A: R.150, P.186, I.187, K.188, W.189 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:P.186, A:W.189 Hydrogen bonds: A:V.185, A:V.185, A:I.187, A:K.188 Salt bridges: A:R.150, A:K.188

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Amrhein, J.A. et al., Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19. J.Med.Chem. (2022)

Release Date

2022-11-23

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence